A phase 1/1b trial of PUR1900 in healthy normal volunteers and patients with asthma
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2017
At a glance
- Drugs PUR 1900 (Primary) ; Itraconazole
- Indications Asthma; Cystic fibrosis-associated respiratory tract infections
- Focus Adverse reactions; Pharmacokinetics
- 09 Nov 2017 According to a Pulmatrix media release, the company expected to initiate dosing in early 2018.
- 08 Aug 2017 Planned initiation date changed to 1 Jan 2018.
- 04 Aug 2017 According to a Pulmatrix media release, the company expected to initiate this study in early Q1 2018 with data readout in Q2 2018.